Your browser doesn't support javascript.
loading
Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study.
Noyce, Alastair J; Kia, Demis A; Hemani, Gibran; Nicolas, Aude; Price, T Ryan; De Pablo-Fernandez, Eduardo; Haycock, Philip C; Lewis, Patrick A; Foltynie, Thomas; Davey Smith, George; Schrag, Anette; Lees, Andrew J; Hardy, John; Singleton, Andrew; Nalls, Mike A; Pearce, Neil; Lawlor, Debbie A; Wood, Nicholas W.
Afiliación
  • Noyce AJ; Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, United Kingdom.
  • Kia DA; Centre for Neuroscience and Trauma, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Hemani G; Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, United Kingdom.
  • Nicolas A; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.
  • Price TR; School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
  • De Pablo-Fernandez E; Laboratory for Neurogenetics, National Institute on Aging National Institutes of Health, Bethesda, Maryland, United States of America.
  • Haycock PC; Laboratory for Neurogenetics, National Institute on Aging National Institutes of Health, Bethesda, Maryland, United States of America.
  • Lewis PA; Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, United Kingdom.
  • Foltynie T; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.
  • Davey Smith G; School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
  • Schrag A; School of Pharmacy, University of Reading, Reading, United Kingdom.
  • Lees AJ; Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, University College London, London, United Kingdom.
  • Hardy J; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.
  • Singleton A; School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
  • Pearce N; Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, United Kingdom.
  • Lawlor DA; Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, United Kingdom.
  • Wood NW; Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, United Kingdom.
PLoS Med ; 14(6): e1002314, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28609445

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Estudio de Asociación del Genoma Completo / Análisis de la Aleatorización Mendeliana Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: PLoS Med Asunto de la revista: MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Estudio de Asociación del Genoma Completo / Análisis de la Aleatorización Mendeliana Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: PLoS Med Asunto de la revista: MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido